CCAP (Crescent Capital BDC) Change In Receivables: $-14.96 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CCAP Crescent Capital BDC Inc CCAP
49 GF Score
Price $11.14
GF Value $6.85
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Crescent Capital BDC Change In Receivables?

Crescent Capital BDC CCAP +1.55% 49 Change In Receivables is $-14.96 Mil as of Mar. 2026. GuruFocus rates CCAP with a GF Score™ of 49/100 and a GF Value™ of $6.85 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Crescent Capital BDC's change in receivables for the quarter that ended in Mar. 2026 was $-6.07 Mil. It means Crescent Capital BDC's Accounts Receivable increased by $6.07 Mil from Dec. 2025 to Mar. 2026 .

Crescent Capital BDC's change in receivables for the fiscal year that ended in Dec. 2025 was $-5.18 Mil. It means Crescent Capital BDC's Accounts Receivable increased by $5.18 Mil from Dec. 2024 to Dec. 2025 .

Crescent Capital BDC's Accounts Receivable for the quarter that ended in Mar. 2026 was $0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Crescent Capital BDC's liquidation value for the three months ended in Mar. 2026 was $-937.49 Mil.

Crescent Capital BDC  (NAS:CCAP) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Crescent Capital BDC's Days Sales Outstanding for the quarter that ended in Mar. 2026 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0/-13.916*91
=

2. In Ben Graham's calculation of liquidation value, Crescent Capital BDC's accounts receivable are only considered to be worth 75% of book value:

Crescent Capital BDC's liquidation value for the quarter that ended in Mar. 2026 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=6.139-943.626+0.75 * 0+0.5 * 0
=-937.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Crescent Capital BDC Change In Receivables Related Terms

Crescent Capital BDC Change In Receivables Historical Data

* Premium members only.

The historical data trend for Crescent Capital BDC's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Crescent Capital BDC Change In Receivables Chart

Crescent Capital BDC Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -17.77 11.68 -4.30 2.08 -5.18

Crescent Capital BDC Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.71 -15.83 9.08 -2.14 -6.07
CCAP
49GF Score
Crescent Capital BDC Inc CCAP
Change In Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Crescent Capital BDC Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-14.96 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of $-14.96 Mil mean?
Crescent Capital BDC (CCAP) has a Change In Receivables of $-14.96 Mil as of Mar. 2026. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Crescent Capital BDC and its competitors.
Is Crescent Capital BDC's Change In Receivables too high?
Crescent Capital BDC's current Change In Receivables is $-14.96 Mil. Overall, Crescent Capital BDC has a GF Score™ of 49/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Crescent Capital BDC's Change In Receivables compare to INV and LEO?
Crescent Capital BDC's Change In Receivables of $-14.96 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for an Asset Management company?
A good Change In Receivables depends on the Asset Management industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Crescent Capital BDC and its competitors. Crescent Capital BDC's current Change In Receivables is $-14.96 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Crescent Capital BDC stock overvalued right now?
Based on GuruFocus' analysis, Crescent Capital BDC (CCAP) is currently considered Significantly Overvalued. The stock's GF Value™ is $6.85, compared to a current price of $11.14 — trading 62.6% above its estimated fair value. The current Change In Receivables is $-14.96 Mil. Crescent Capital BDC's overall GF Score™ is 49/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Crescent Capital BDC (CCAP), the current Change In Receivables is $-14.96 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Crescent Capital BDC (CCAP) Overvalued in 2026?

Based on GuruFocus' analysis, Crescent Capital BDC stock appears to be overvalued. The current stock price of $11.14 is trading 62.6% above its estimated GF Value™ of $6.85. GuruFocus considers Crescent Capital BDC to be Significantly Overvalued.

Key valuation signals for CCAP:

  • Change In Receivables: $-14.96 Mil
  • GF Value™: $6.85 vs. price of $11.14 (62.6% above fair value)
  • GF Score™: 49/100 with 4 warning signs

No single metric tells the full story. See the CCAP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Crescent Capital BDC Business Description

Other Exchanges 487:Germany
Address 11100 Santa Monica Boulevard, Suite 2000, Los Angeles, CA, USA, 90025
Crescent Capital BDC Inc is a business development company structured as an externally managed, closed-end, non-diversified management investment company. The company's primary investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through debt and related equity investments. It will seek to achieve its investment objectives by investing in secured debt (including senior secured, unitranche, and second lien debt) and unsecured debt (including senior unsecured, mezzanine, and subordinated debt), as well as related equity securities of private U.S. middle-market companies.
49GF Score

Get the complete analysis for CCAP

Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$11.14
Price
$6.85
GF Value